Want to see CALC full AI Analyst Report?
Total Valuation
CalciMedica has a market cap or net worth of $21.78M. The enterprise value is $8.20.
Market Cap$21.78M
Enterprise Value$8.20
Share Statistics
CalciMedica has 34,141,460 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding34,141,460
Owned by Insiders20.13%
Owned by Institutions26.44%
Financial Efficiency
CalciMedica’s return on equity (ROE) is 4.45 and return on invested capital (ROIC) is -209.07%.
Return on Equity (ROE)4.45
Return on Assets (ROA)-2.18
Return on Invested Capital (ROIC)-209.07%
Return on Capital Employed (ROCE)-2.36
Revenue Per Employee0.00
Profits Per Employee-1.85M
Employee Count16
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of CalciMedica is ―. CalciMedica’s PEG ratio is -0.05.
PE Ratio―
PS Ratio0.00
PB Ratio-14.90K
Price to Fair Value-14.90K
Price to FCF-4.66K
Price to Operating Cash Flow-0.55
PEG Ratio-0.05
Income Statement
In the last 12 months, CalciMedica had revenue of 0.00 and earned -29.56M in profits. Earnings per share was -1.97.
Revenue0.00
Gross Profit0.00
Operating Income-23.12M
Pretax Income-29.56M
Net Income-29.56M
EBITDA-28.09M
Earnings Per Share (EPS)-1.97
Cash Flow
In the last 12 months, operating cash flow was -19.11M and capital expenditures -14.00K, giving a free cash flow of -19.12M billion.
Operating Cash Flow-19.11M
Free Cash Flow-19.12M
Free Cash Flow per Share-0.56
Dividends & Yields
CalciMedica pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.32
52-Week Price Change-77.71%
50-Day Moving Average0.79
200-Day Moving Average1.88
Relative Strength Index (RSI)40.71
Average Volume (3m)71.94K
Important Dates
CalciMedica upcoming earnings date is Nov 18, 2026, After Close (Confirmed).
Last Earnings DateAug 11, 2026
Next Earnings DateNov 18, 2026
Ex-Dividend Date―
Financial Position
CalciMedica as a current ratio of 3.58, with Debt / Equity ratio of 0.00%
Current Ratio3.58
Quick Ratio3.58
Debt to Market Cap<0.01
Net Debt to EBITDA0.06
Interest Coverage Ratio-16.26
Taxes
In the past 12 months, CalciMedica has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
CalciMedica EV to EBITDA ratio is -3.52K, with an EV/FCF ratio of -4.66K.
EV to Sales0.00
EV to EBITDA-3.52K
EV to Free Cash Flow-4.66K
EV to Operating Cash Flow-4.67K
Balance Sheet
CalciMedica has $18.62M in cash and marketable securities with $0.00 in debt, giving a net cash position of $18.62M billion.
Cash & Marketable Securities$18.62M
Total Debt$0.00
Net Cash$18.62M
Net Cash Per Share$0.55
Tangible Book Value Per Share>-$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for CalciMedica is ―, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target―
Price Target Upside―
Analyst ConsensusHold
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast15.37%